Neuphoria Therapeutics Inc. Company Profile
NASDAQ: NEUPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.41-0.01 (-0.29%)
Market open · Delayed 15 min · as of Oct 8, 12:18 PM ET
Neuphoria Therapeutics at a glance
Neuphoria Therapeutics Inc. (NASDAQ: NEUP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $18.7 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001191070, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Neuphoria Therapeutics Inc.
- Ticker
- NASDAQ: NEUP
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2021
- Market cap
- $18.67M
- SEC CIK
- 0001191070
Companies similar to Neuphoria Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AKTXAkari Therapeutics plc ADS | 8.44 | -2.14% | $19.29M | vs NEUP |
| QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares | 3.13 | -0.57% | $20.11M | vs NEUP |
| PTNPalatin Technologies Inc. | 9.55 | +0.32% | $17.01M | vs NEUP |
| MRKRMarker Therapeutics Inc. | 1.02 | -2.31% | $16.94M | vs NEUP |
| COCPCocrystal Pharma Inc. | 1.06 | -0.91% | $20.42M | vs NEUP |
| NCELNewcelX Ltd. | 2.90 | -4.45% | $16.75M | vs NEUP |
| LPCNLipocine Inc. | 1.99 | -9.55% | $16.41M | vs NEUP |
| RADXRadiopharm Theranostics Limited ADR | 1.12 | -2.61% | $16.34M | vs NEUP |